Dr. Panda's Newsletter

Share this post

User's avatar
Dr. Panda's Newsletter
Stop Taking Molnupiravir - The COVID Antiviral

Stop Taking Molnupiravir - The COVID Antiviral

It's ineffective but that's not the most interesting part

Dr Panda's avatar
Dr Panda
Dec 24, 2022
∙ Paid
55

Share this post

User's avatar
Dr. Panda's Newsletter
Stop Taking Molnupiravir - The COVID Antiviral
18
Share

Merry Christmas Eve everyone!

I want to bring your attention to a new study in The Lancet. Researchers conducted a fairly large randomized trial and found the drug failed to reduce hospitalizations or deaths.

What is Molnupiravir?

Molnupiravir is an oral antiviral drug acting as a nucleoside analogue developed by Merck. It works by disrupting viral repl…

Keep reading with a 7-day free trial

Subscribe to Dr. Panda's Newsletter to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Dr. Panda
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share